Middle East & Africa Pharmacogenetic Testing Market to 2032
Overview
The Middle East & Africa Pharmacogenetic Testing Market is expected to reach a 267.03 USD Million by 2032 and is projected to grow at a CAGR of 7.62% from 2025 to 2032.
Revenue, 2024 (USD Million)
173.54
Forecast, 2032 (USD Million)
267.03
CAGR, 2024 - 2032
7.62%
Report Coverage
Middle East & Africa
Middle East & Africa Pharmacogenetic Testing Market 2018-2032 USD Million
Middle East & Africa Pharmacogenetic Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 173.54 USD Million
- Projected Market Size (2032): 267.03 USD Million
- CAGR (2025-2032): 7.62%
Key Findings of Middle East & Africa Pharmacogenetic Testing Market
- The Middle East & Africa Pharmacogenetic Testing Market was valued at 173.54 USD Million in 2024.
- The Middle East & Africa Pharmacogenetic Testing Market is likely to grow at a CAGR of 7.62% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Blood in Sample Segment accounted for the largest share of the market with a revenue of 99.80 USD Million
- The fastest growing segment CYP2C19 in Gene Segment grew Fastest with a CAGR of 11.93% during the forecast period from 2024 to 2032.
Middle East & Africa Pharmacogenetic Testing Market Scope
Middle East & Africa Pharmacogenetic Testing Market Segmentation & Scope
Gene
- Others
- TMPT
- HTR2A/C
- SLC6A4
- D4D4
- DRD3
- ONCOTYPE DX® AND MAMMAPRINT®
- OPRM1
- CYP2D
- HLA-B*5701
- HLA-B*1502
- CYP1A2
- CYP2C9 AND VKORC1
- CYP2D6
- CYP2C19
Type
- Single Gene Tests
- Array-Based Tests
- Whole Exome Sequencing
- Whole Genome Sequencing
Therapeutic Area
- Others
- Neurology
- Oncology
- Gynecology
- Dermatology
- Immunology & Hypersensitivity
- Endocrinology
- Genomics
- Anesthesiology
- Gastroenterology
- Cardiology
Sample
- Saliva
- Blood
Drug
- Over-the-Counter Medications
- Vitamins
- Herbal Supplements
- Recreational Drugs
- Nutraceuticals
- Prescription Drugs
Application
- Drug Regulation
- Drug Development
- Clinical Practice
End User
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Healthcare Providers
Distribution Channel
- Direct-to-Customer Services
- Mail-Order Pharmacies
- Retail Pharmacies
- Hospital Pharmacy
Middle East & Africa Pharmacogenetic Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 173.54 USD Million |
| Market Value in 2032 | 267.03 USD Million |
| CAGR (2025-2032) | 7.62% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Gene,Type,Therapeutic Area,Sample,Drug,Application,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 173.54 USD Million in 2024
- Key Country: South Africa, leading in terms of revenue with value of 77.74 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Pharmacogenetic Testing Market to 2032, By Gene
- CYP2C19 is the largest segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a revenue of 29.30 USD Million in the year 2024.
- CYP2C19 is the Fastest growing segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a Growth rate of 11.93 % in forecast period 2025-2032.
-
Middle East & Africa Pharmacogenetic Testing Market to 2032, By Type
- Whole Genome Sequencing is the largest segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a revenue of 89.05 USD Million in the year 2024.
- Whole Genome Sequencing is the Fastest growing segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a Growth rate of 8.10 % in forecast period 2025-2032.
-
Middle East & Africa Pharmacogenetic Testing Market to 2032, By Therapeutic Area
- Cardiology is the largest segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a revenue of 35.73 USD Million in the year 2024.
- Cardiology is the Fastest growing segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a Growth rate of 10.98 % in forecast period 2025-2032.
-
Middle East & Africa Pharmacogenetic Testing Market to 2032, By Sample
- Blood is the largest segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a revenue of 99.80 USD Million in the year 2024.
- Blood is the Fastest growing segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a Growth rate of 7.77 % in forecast period 2025-2032.
-
Middle East & Africa Pharmacogenetic Testing Market to 2032, By Drug
- Prescription Drugs is the largest segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a revenue of 61.66 USD Million in the year 2024.
- Prescription Drugs is the Fastest growing segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a Growth rate of 8.61 % in forecast period 2025-2032.
-
Middle East & Africa Pharmacogenetic Testing Market to 2032, By Application
- Clinical Practice is the largest segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a revenue of 84.53 USD Million in the year 2024.
- Clinical Practice is the Fastest growing segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a Growth rate of 8.04 % in forecast period 2025-2032.
-
Middle East & Africa Pharmacogenetic Testing Market to 2032, By End User
- Healthcare Providers is the largest segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a revenue of 76.36 USD Million in the year 2024.
- Healthcare Providers is the Fastest growing segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a Growth rate of 8.24 % in forecast period 2025-2032.
-
Middle East & Africa Pharmacogenetic Testing Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a revenue of 84.44 USD Million in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in Middle East & Africa Pharmacogenetic Testing Market to 2032 with a Growth rate of 8.11 % in forecast period 2025-2032.
Middle East & Africa Pharmacogenetic Testing Market Company Share Analysis
| Company Name |
|
||
| Illumina, Inc. | |||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Sonic Healthcare Limited | |||
| BGI | |||
Middle East & Africa Pharmacogenetic Testing Market Geographical Sales Distribution, 2018-2032 USD Million
Middle East & Africa Pharmacogenetic Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Pharmacogenetic Testing Market is segmented based on Segmentation Gene,Type,Therapeutic Area,Sample,Drug,Application,End User,Distribution Channel.
Middle East & Africa Pharmacogenetic Testing Market was valued at USD 173.54(Revenue in USD Million) in 2021.
Middle East & Africa Pharmacogenetic Testing Market is projected to grow at a CAGR of 7.62% during the forecast period of 2024 to 2032.
The Blood segment is expected to dominate the Middle East & Africa Pharmacogenetic Testing Market, holding a largest market share of 99.80 USD Million in 2024
Middle East & Africa Pharmacogenetic Testing Market Scope
Middle East & Africa Pharmacogenetic Testing Market Segmentation & Scope
Gene
- Others
- TMPT
- HTR2A/C
- SLC6A4
- D4D4
- DRD3
- ONCOTYPE DX® AND MAMMAPRINT®
- OPRM1
- CYP2D
- HLA-B*5701
- HLA-B*1502
- CYP1A2
- CYP2C9 AND VKORC1
- CYP2D6
- CYP2C19
Type
- Single Gene Tests
- Array-Based Tests
- Whole Exome Sequencing
- Whole Genome Sequencing
Therapeutic Area
- Others
- Neurology
- Oncology
- Gynecology
- Dermatology
- Immunology & Hypersensitivity
- Endocrinology
- Genomics
- Anesthesiology
- Gastroenterology
- Cardiology
Sample
- Saliva
- Blood
Drug
- Over-the-Counter Medications
- Vitamins
- Herbal Supplements
- Recreational Drugs
- Nutraceuticals
- Prescription Drugs
Application
- Drug Regulation
- Drug Development
- Clinical Practice
End User
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Healthcare Providers
Distribution Channel
- Direct-to-Customer Services
- Mail-Order Pharmacies
- Retail Pharmacies
- Hospital Pharmacy
Frequently Asked Questions
The Middle East & Africa Pharmacogenetic Testing Market is segmented based on Segmentation Gene,Type,Therapeutic Area,Sample,Drug,Application,End User,Distribution Channel.
Middle East & Africa Pharmacogenetic Testing Market was valued at USD 173.54(Revenue in USD Million) in 2021.
Middle East & Africa Pharmacogenetic Testing Market is projected to grow at a CAGR of 7.62% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Pharmacogenetic Testing Market for final year is USD 267.03 (USD Million).
Middle East & Africa Pharmacogenetic Testing Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Pharmacogenetic Testing Market is segmented based on Segmentation Gene,Type,Therapeutic Area,Sample,Drug,Application,End User,Distribution Channel.
Middle East & Africa Pharmacogenetic Testing Market was valued at USD 173.54(Revenue in USD Million) in 2021.
Middle East & Africa Pharmacogenetic Testing Market is projected to grow at a CAGR of 7.62% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Pharmacogenetic Testing Market for final year is USD 267.03 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.